Navigation Links
Former GlaxoSmithKline Senior Executive Agnes Westelinck Joins NDA Partners as a Premier Expert Consultant
Date:8/16/2014

Madison, Virginia (PRWEB) August 16, 2014

Dr. Carl Peck, MD, Chairman of NDA Partners LLC announced today that Agnes Westelinck, PharmD, has joined the firm as a Premier Expert consultant. NDA Partners Premier Experts are top tier consultants whose expertise and professional stature enable them to bring extraordinary value to the company’s clients. Premier Experts collaborate to design and implement critical solutions to help clients successfully develop their medical products, pursue optimal regulatory pathways, build companies that are attractive to professional investors, and initiate access to global markets. Dr. Westelinck is a highly regarded pharmaceutical industry senior executive with significant experience in the development and regulatory approval of drugs in the US, EU and Asia. She was formerly Executive Director and Global Head of Regulatory Affairs, Oncology, for GlaxoSmithKline, Director of Regulatory Affairs at Hoffman-La Roche, and Visiting Scientist/Executive at the US Food & Drug Administration (FDA), Office of Drug Evaluation, Division of Oncology (CDER).

“Dr. Westelinck brings an extraordinary level of knowledge and expertise in oncology research, product development, and regulatory pathways in both the US and EU that will greatly benefit our clients in this field,” said Dr. Peck. “Oncology is presently a very active area for new drug development and we welcome Dr. Westelinck as a key contributor and leader in this practice area.”

In addition to global product development and regulatory strategy, Dr. Westelinck’s expertise includes innovative approaches in drug development (targeted therapies, immunotherapy, breakthrough therapies, novel-novel combinations, companion diagnostics, and innovative study designs) and emerging technologies (cell therapies, therapeutic RNA). She also provides strategic input for portfolio and licensing/deal-making decisions, and guidance for IND and NDA submissions, rare diseases, biomarkers, and accelerated approvals.

About NDA Partners
NDA Partners is a strategy consulting firm specializing in expert product development and regulatory advice to the medical products industry and associated service industries such as law firms, investment funds and government research agencies. The highly experienced Principals and Premier Experts of NDA Partners include two former FDA Center Directors; the former Chairman of the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK; an international team of approximately 40 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, expert consulting, high-impact project teams, and virtual product development teams.

Read the full story at http://www.prweb.com/releases/2014/08/prweb12095501.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Fox Insurance Company Awarded $3.3 Million in Arbitration Against Former Pharmacy Benefit Manager
2. Former Sanofi-aventis and US Oncology Executive Joins New Century Health as Chief Executive Officer
3. PAREXEL Appoints Former Senior FDA Official David Elder to Global Team of Strategic Compliance Experts
4. PharmaVentures Helps Secure Investor for Former MSD Research Site
5. Dr. Michael Yaremchuk, Leading Performer of Custom-Designed Facial Implants, Pioneers Bespoke Plastic Surgery
6. Former FDA Inspectors Train Medical Device, Pharmaceutical Companies How to Prepare for FDA Inspections of Their Quality Systems
7. Ceres Expands Board of Directors with former BP Chief Scientist and Undersecretary of Energy Steven Koonin
8. Former Stryker CEO Takes Reins at sBioMed
9. Lucas Bagnell Varga LLC Secures $17.4 Million Award For Former Applied Biosystems Executives
10. Non-Intrusive Black Mold Removal Procedure Released By Former Mold Remediation Specialist, MyCleaningProducts.com Explains
11. Delta Point Strengthens Management and Expands Consultancy Services with Addition of Former AstraZeneca Executive Michael Hickey
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/9/2018)... ... 2018 , ... Since their establishment in 2012, ambitions have been high at ... its’ size from last year, the company is thrilled to announce the release of ... crowds at a private product launch event during the annual Protein Society Symposium in ...
(Date:8/7/2018)... ... August 06, 2018 , ... Slone ... announces the placement of Dr. Paul Harney as President, North America at Prescient ... strategy and enhancing client satisfaction. He was also named to Prescient’s Board of ...
(Date:7/31/2018)... (PRWEB) , ... July 31, 2018 , ... ... 2 additional CE/IVD marked molecular quality controls to its expanding CE/IVD product inventory. ... controls to our expanding CE/IVD QC offerings. ZeptoMetrix remains entirely committed to fully ...
(Date:7/25/2018)... , ... July 25, 2018 , ... ... on the significant impact of a biofield energy treated nutraceutical to improve skin ... research assessed biomarkers for skin health and reported the following results:, ...
Breaking Biology Technology:
(Date:8/9/2018)... ... August 08, 2018 , ... ... to invest in disruptive technology and healthcare companies, has invested in a sought-after ... stealth mode. , CRISPR Technology and Mammoth Biosciences , The biotech company ...
(Date:8/7/2018)... ... August 06, 2018 , ... ... highly successful business intelligence platform. Inspired by its medical device customers, BioMedGPS teamed ... experience on-site. Among the many changes, SmartTRAK 3.0 touts a cleaner look, easier ...
(Date:8/2/2018)... ... August 02, 2018 , ... The American College ... Heart Diagnostics to its Lifestyle Medicine Corporate Roundtable, a group of individuals and ... and a sustainable world. , Boston Heart is transforming the treatment of ...
Breaking Biology News(10 mins):